Ceres Pharmaceuticals, Ltd.
Records under this name other than patents Ceres Pharmaceuticals, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Ceres Pharmaceuticals, Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,083,787 | Yeast-dendritic cell vaccines and uses thereof Formerly held Term ended Term ended Sep 14, 2022 · USPTO record | Term ended | Term ended Sep 14, 2022 | USPTO record |
| US 7,595,060 | Yeast-Antigen Compositions Methods of Making the Same Formerly held Term ended Ended no later than Nov 15, 2021 · Low confidence | Term ended | Ended no later than Nov 15, 2021 | Low confidence |
| US 8,221,763 | Yeast-Antigen Compositions and Methods of Using the Same Formerly held Term ended Ended no later than Nov 15, 2021 · Low confidence | Term ended | Ended no later than Nov 15, 2021 | Low confidence |